Great American wines under $20
Wine treasures selling in the $10-to-$20 range
America’s wine shops are filled with consistently good, drinkable, cheap bottles, said Eric Asimov in The New York Times. “Such a bore!” The real challenge is to find inexpensive American wines that also “fascinate and intrigue.” The “sweet spot nowadays for great values” lies in wine treasures selling in the $10-to-$20 range. Some bottles may be hard to find, but each offers a distinctive complexity that gives “so much pleasure.”
Gruet New Mexico Brut Blanc de Noirs NV ($12.99)
“A perennial steal.” Fresh and lively.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Lieb North Fork of Long Island Pinot Blanc 2007 ($18.99)
“What a delicious wine!” Dry and creamy.
Quivira Dry Creek Valley Zinfandel 2005 ($19.99)
Classic peppery flavors.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Edmunds St. John El Dorado County Bone-Jolly Gamay Noir Rosé 2008 ($19.99)
“Let us not forget rosé.” Made from a rare strand of Gamay in the Sierra foothills.
Create an account with the same email registered to your subscription to unlock access.
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published